AB-205

AB-205 · Angiocrine Bioscience

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AB-205, covering 2025-02-04 to 2025-02-04. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the Effects of AB-205 in Patients With Lymphoma Undergoing Autologous Hematopoietic Cell Transplantation [Phase 3]

See pricing